Nir Sassi - Apr 10, 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Financial Officer
Signature
/s/ Nir Sassi
Stock symbol
INDP
Transactions as of
Apr 10, 2025
Transactions value $
-$500
Form type
4
Date filed
4/11/2025, 04:15 PM
Previous filing
Oct 10, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Disposed to Issuer -$89 -1.25K -100% $0.07 0 Apr 10, 2025 Common Stock 1.25K $25.72 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$80 -1.13K -100% $0.07 0 Apr 10, 2025 Common Stock 1.13K $34.32 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$178 -2.5K -100% $0.07 0 Apr 10, 2025 Common Stock 2.5K $72.00 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$36 -500 -100% $0.07 0 Apr 10, 2025 Common Stock 500 $357.28 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$36 -500 -100% $0.07 0 Apr 10, 2025 Common Stock 500 $357.28 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$3 -41 -100% $0.07 0 Apr 10, 2025 Common Stock 41 $331.20 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$80 -1.13K -100% $0.07 0 Apr 10, 2025 Common Stock 1.13K $610.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.